A novel high sensitivity bacteriophage-based assay identifies low level Mycobacterium tuberculosis bacteraemia in immunocompetent patients with active and incipient tuberculosis by Verma, Raman et al.





Evidence of Mycobacterium tuberculosis Complex bacteraemia in intradermal skin test 2 
positive cattle detected using phage-RPA  3 
 4 
Authors 5 
Benjamin M. C. Swifta#, Thomas W. Converyb, Catherine E. D. Reesb 6 
 7 
Affiliations 8 
aSchool of Veterinary Medicine and Science,  bSchool of Biosciences, University of 9 
Nottingham, Sutton Bonington Campus, UK.  10 
 11 
Running Title 12 
Detection of bacteraemia in TB reactor animals 13 
 14 
#Corresponding Author: B M C Swift; email: benjamin.swift@nottingham.ac.uk 15 
 16 
T.W.C. and C.E.D.R contributed equally to this work.  17 





    Bovine tuberculosis is a zoonotic infectious disease caused by Mycobacterium bovis 19 
that affects cattle and can cause tuberculosis in a range of wildlife animals. A 20 
bacteriophage-based method combined with PCR (phage-PCR) has been recently used to 21 
detect and identify viable pathogenic mycobacteria in the peripheral blood mononuclear 22 
cells (PBMCs) of animals suffering from paratuberculosis. To adapt this method for the 23 
detection of M. bovis in blood, a new isothermal DNA amplification protocol using 24 
Recombinase Polymerase Amplification (RPA) was developed and was found to be able to 25 
detect M. bovis BCG within 48 h, with a limit of detection of approximately 10 cells per 26 
ml of blood for artificially inoculated blood samples. When blood samples (2 ml) from a 27 
Single Comparative Cervical Intradermal Tuberculin (SCCIT)- negative beef herd were 28 
tested, Mycobacterium tuberculosis complex (MTC) cells were not detected from any 29 
(45) of the blood samples. However when blood samples from SCCIT-positive animals 30 
were tested, viable MTC bacteria were detected in 66 % (27/41) of samples. Of these 41 31 
animals sampled, 32 % (13) had visible lesions. In the visible lesion (VL) group, 85 % 32 
(11/13) had detectable levels of MTC whereas only 57 % (16/28) of animals which had 33 
no visible lesions (NVL) were found to have detectable mycobacteraemia. These results 34 
indicated that this simple, rapid method can be applied for the study of M. bovis 35 
infections.  The frequency with which viable mycobacteria were detected in the 36 
peripheral blood of SCCIT-positive animals changes the paradigm of this disease.    37 





    Mycobacterium bovis is the causative agent of bovine tuberculosis and forms part of 39 
Mycobacterium tuberculosis Complex group of pathogens. Bovine tuberculosis is a 40 
disease that affects primarily cattle, but can infect humans as well as a variety of other 41 
domestic and wild mammals.1  Despite eradication schemes being in place since the 42 
1950’s, the UK has struggled to eradicate the disease; in fact the incidence of BTB 43 
outbreaks has increased and control measures continue to be a significant economic 44 
burden for this UK agriculture sector.2  A major barrier to understanding and diagnosing 45 
M. bovis infection is that culture of these slow growing organisms is difficult, time 46 
consuming and often impracticable. This is especially true when undertaking 47 
epidemiological, infection or immunological studies compared to bacterial load.3 In 48 
addition to the long incubation times required, a specific limitation of culture is that 49 
chemical decontamination used to inhibit the growth of competing bacteria also reduces 50 
the viability of the mycobacterial cells present in samples, reducing the sensitivity and 51 
reliability of culture as a method to detect and understand the disease.4  52 
    Essentially due to these difficulties, an area of bovine tuberculosis pathophysiology 53 
that is underreported is the development of disseminated infection and bacteraemia. It is 54 
known that M. bovis infection in an animal can have a number of possible outcomes 55 
ranging from elimination, self-limiting infection, localized lesions or a life-threatening 56 
systemic disease. The immune response following challenge is known to be complex, 57 
with variable responses occurring during natural infections with low numbers of 58 
organisms.5 Bacteraemia occurs during post-primary dissemination in humans and it has 59 
been reported, although rarely, in cattle.6 Recently a study in India reported the culture 60 
of M. bovis in the blood of apparently healthy cattle, which suggested M. bovis may be 61 
circulating in the blood of sub-clinically infected animals at higher levels than expected.7 62 
The paucity of information concerning this aspect of the disease means that it is not 63 
known whether bacteraemia will ultimately lead to active infection or clearance, nor how 64 
a positive SCCIT test result relates to the potential for bacteraemia. 65 




    Bacteriophage amplification technology was developed 20 years ago as a method to 66 
rapidly detect and enumerate slow growing pathogenic mycobacteria.8 In addition it can 67 
be used as a tool to rapidly detect antibiotic resistance9 and to investigate mycobacterial 68 
dormancy.10 The assay detects the growth of broad host range mycobacteriophage, 69 
capable of infecting a wide range of both pathogenic and non-pathogenic mycobacteria. 70 
As the phage is specific for members of the Mycobacterium genus, and can only 71 
successfully replicate within a viable cell, a positive test result (a plaque) indicates the 72 
presence of viable mycobacterial cells in the original sample.  The specificity of the 73 
detection event is then achieved by amplification of signature sequences from the plaque 74 
following the phage assay (see Fig 1;11).  In contrast, direct PCR will detect DNA from 75 
both viable and non-viable cells and can be inhibited by components in the blood.12 The 76 
combined phage-PCR method has been shown to be able to detect and enumerate 77 
Mycobacterium avium subsp. paratuberculosis (MAP) in a range of matrices such as milk, 78 
cheese and blood,11, 13, 14 but detection of M. bovis in clinical samples using this approach 79 
has not been described before.  80 
    It was already known that the phage-PCR assay could be used to sensitively detect M. 81 
bovis cells from liquid cultures15 and that this method can be used to detect MAP cells in 82 
clinical blood samples.16 The aim of these experiments was to design and optimise a 83 
phage-PCR method to allow detection of M. bovis cells in blood and to determine 84 
whether it could detect mycobacteria in SCCIT-positive animals.  85 
 86 
Materials and Methods 87 
Bacterial strains, bacteriophage and growth media 88 
    M. bovis BCG (Glaxo) was used to optimise the phage-PCR assay. Cells were cultured 89 
and maintained on Middlebrook 7H10 agar supplemented with OADC (Becton Dickenson, 90 
UK) without glycerol and liquid cultures were prepared in Middlebrook 7H9 media 91 
(Becton Dickenson, UK) containing OADC. When performing the phage assay the media 92 
was supplemented with CaCl2 (2 mM final concentration; Sigma, UK). All cultures were 93 
grown at 37 oC without shaking to prevent clumping. For the phage assays the 94 




Mycobacterium smegmatis strain used was mc2155 (Lab21 Ltd, UK) and the 95 
bacteriophage used was D29 (Lab21 Ltd, UK).   96 
 97 
Bacteriophage amplification assay 98 
    The phage assay (Fig. 1) and experimental controls were carried out as previously 99 
described.15,16  Briefly, samples (1 ml) were mixed with bacteriophage D29 (100 µl; 1 x 100 
108 pfu) in supplemented 7H9 Media and incubated for 1 h to allow the phage to infect 101 
any mycobacteria present in the sample. Phage that had not infected a host cell were 102 
then inactivated using a virucide (100 µl ferrous ammonium sulphate; final concentration 103 
10 mM; Lab21 Ltd, UK).  Samples were mixed thoroughly ensuring all sides of the 104 
container are covered and incubated for 5 min at room temperature. 1 ml of M. 105 
smegmatis cells (to form the bacterial lawn) was added to the sample which was plated 106 
in 7H10 agar (0.75 % final agar concentration). As experimental controls, a 1 ml sample 107 
containing approx. 1 x 103 cfu ml-1 M. smegmatis cells or 1 ml of medium alone were 108 
used as positive and negative controls, respectively for the phage assays.  Plaques 109 
formed at the end of the assay were counted and the number taken to represent the 110 
number of cells that could be detected by the phage in the sample.  111 
  112 
Molecular Identification of M. tuberculosis Complex cells 113 
    The identity of the mycobacterial cell detected was determined by extracting DNA 114 
from the centre of plaques (a maximum of 5) using agarose gel-DNA extraction columns 115 
(ZymoResearch, UK).16 For PCR detection of MTC DNA, the IS6110 PCR assay described 116 
by Eisenach17 was used. In a 25 µl reaction volume, 1 µM of each primer was used with 117 
HotStarTaq Plus Master Mix Kit (Qiagen, UK). The PCR cycle conditions were 95 oC for 5 118 
min followed by 30 cycles of 95 oC for 30s, 68 oC for 30 s and 72 oC for 1 min and a final 119 
extension at 72 oC for 7 min. Either IS6110 or IS108118 was targeted for RPA detection 120 
using lyophilised reagents (TwistDx Ltd, UK). These were rehydrated using 37.5 µL 121 
TwistAmp Resuspension Buffer and 4 µL of 280 mM MgOAc. Template DNA (8.5 µL) was 122 
added to this and samples were incubated for 30 min at 39 oC. DNA extracted from M. 123 




bovis BCG and sterile water were used as positive and negative controls, respectively. 124 
Amplified RPA products of approximately 220 bp were visualised using agarose gel DNA 125 
electrophoresis.  126 
    To determine the sensitivity of the RPA assay, agar extracted from M. bovis BCG 127 
plaques was mixed with agar extracted from plaques formed using the non-pathogen M. 128 
smegmatis.  The number of M. bovis plaques added varied between 1 and 5, with the 129 
total number of plaques per sample being made up to 5 in each case using M. 130 
smegmatis plaques. DNA samples extracted from these mixtures were then subsequently 131 
tested using either the PCR or RPA assays described above. 132 
 133 
Blood samples, preparation and isolation of Peripheral Blood Mononuclear Cells 134 
    For method optimisation experiments commercial heparinised sheep blood (Oxoid, 135 
UK) was used. The number of M. bovis BCG cells in laboratory cultures was enumerated 136 
using the bacteriophage assay as described above (data reported as pfu.ml-1)8 and then 137 
cells diluted in PBS (105 to 10 pfu ml-1).  To allow uptake of bacterial cells by leukocytes 138 
the method of 19 was used. Briefly 1 ml of cell suspension was added to 9 ml fresh (< 1 139 
d old) heparinised sheep blood and samples incubated at 37 °C on a rotating mixer for 4 140 
h. After the uptake period, PBMCs were isolated from 2 ml blood using Ficoll-Paque Plus 141 
in Leucosep tubes (GE Healthcare Life Sciences, UK). The purified PBMC’s were then 142 
lysed by osmotic shock by addition of supplemented 7H9 media to release any 143 
internalised bacteria. The phage assay was then performed to detect mycobacteria 144 
released from the PBMCs as described above.11  145 
    Clinical blood samples from the SCCIT-positive cattle were obtained directly after 146 
slaughter by a veterinary surgeon in the abattoir.  These were Holstein cows from a farm 147 
in the South West of the UK within the High Risk zone.  Blood samples from the control 148 
animals were obtained from a closed Holstein beef herd in a non-TB endemic area of the 149 
UK provided as superfluous material as part of an on-going herd health screening 150 
program under the Veterinary Surgeons Act.  The study protocol was approved by the 151 
University of Nottingham, School of Veterinary Medicine and Science ethical review panel 152 




prior to sample usage. Blood was collected in Vacutainer heparin tubes (Becton 153 
Dickenson) and 2 ml samples used for the isolation of the PBMCs which were tested 154 
using the phage assay using the same method described above.   155 
 156 
Statistical analysis 157 
    Excel 2010 statistical add on package was used to initially determine whether the data 158 
were distributed normally or not, then GraphPad Prism was used for performing ANOVAs 159 
and post-hoc tests to determine significant differences in the data. Significance was 160 
determined at p < 0.05. 161 
 162 
Results 163 
Development of phage-PCR method for detection of M. bovis BCG in blood 164 
    An experiment was performed to determine whether the phage assay could also 165 
be used to detect M. bovis BCG cells present inside PBMCs but using a published method 166 
that allows mycobacteria to be taken up by leukocytes.18,19  When using this method, if 167 
no incubation time is allowed for uptake, no mycobacteria are detected in the buffy coat 168 
layer demonstrating that the bacteria do not co-purify with the PBMCs (Table 1).  When 169 
105 M. bovis BCG cells were added to the blood, the number of plaques detected in the 170 
PBMC fraction was uncountable, indicating that the purified PBMCs contained more than 171 
103 cells (Table 1). As the number of cells added to the blood was decreased, the 172 
number of plaques recorded in each sample also decreased until the number of cells 173 
detected in the PBMC fraction reached countable levels.  This occurred when 174 
approximately 102 M. bovis BCG cells were added to the blood, at which point 65 (±13) 175 
plaques were recorded (Table 1) indicating an efficiency of uptake of the M. bovis BCG 176 
cells of at least 50%. If less than 10 M. bovis BCG cells were added to the sample, no 177 
cells were detected using the phage assay and this is consistent with the results gained 178 
when this method was used for the internalisation of MAP.19  Given the efficiency of 179 
uptake, it was assumed that the limit of detection of this method was approximately 10 180 




cells per sample. However it could be lower than this when naturally infected samples 181 
are tested since the cells are already internalised.   182 
 183 
Molecular identification of M. tuberculosis Complex DNA 184 
    Previously we have used PCR to detect the MAP signature genetic elements present in 185 
DNA extracted from individual plaques,14, 15 hence this approach was also applied here 186 
and the IS6110 MTC signature sequence was amplified by PCR using a published 187 
method.17  When the sample was composed of DNA extracted from 5 plaques arising 188 
from the detection of M. bovis BCG cells, the PCR assay was routinely able to detect the 189 
IS6110 element (data not shown). However when the number of M. bovis BCG plaques 190 
varying between 1 and 5, was tested (Table 2), it was found that the PCR assay could 191 
not consistently detect the IS6110 genetic element when only one or two M. bovis BCG 192 
plaques were present in the sample, suggesting that the PCR assay was not sensitive 193 
enough for reliable detection of low amounts of DNA. This is consistent with our 194 
observations when developing an assay for MAP, where it was found that a nested PCR 195 
more consistently detected low concentrations of IS900 in samples that only contained 196 
one MAP-positive plaque.16   197 
     To improve the sensitivity of the molecular detection event, PCR amplification was 198 
replaced with DNA amplification using a published isothermal RPA method.18  Using this 199 
method, both the IS6110 and IS1081 MTC signature sequences were always detected 200 
from DNA samples that contained the DNA extracted from five M. bovis BCG plaques. 201 
However, only the RPA IS6110 primers were able to consistently amplify MTC DNA when 202 
agar was extracted from one M. bovis BCG plaque mixed with 4 M. smegmatis plaques 203 
(Table 2). Thus the RPA method using the IS6110 primers was chosen for use for further 204 
experiments. 205 
 206 
Detection of viable M. tuberculosis Complex cells in clinical blood samples  207 
     Blood samples were obtained from 41 SCCIT-positive animals after slaughter and the 208 
optimised phage-RPA method was used to detect any viable MTC cells present in the 209 




sample. As a control 45 blood samples from cattle in herds with no previous history of M. 210 
bovis infection were also tested.   From the 45 SCCIT-negative samples, six produced 211 
plaques (range = 1-11 per 2 ml blood; mean = 3.1), however none of these gave a 212 
positive IS6110 RPA result (Table 3) indicating that no MTC DNA was detected in these 213 
samples. We have previously reported that the phage assay will produce low numbers of 214 
plaques from samples that do not give a positive result when interrogated using PCR.15 215 
However the plaque number in these samples is always low as seen here.   216 
    Within the SCCIT-positive group, 31 produced plaques. After DNA extraction, 27 of 217 
these samples produced a positive IS6110 RPA result (Table 4) indicating that DNA from 218 
MTC bacteria was present. At post mortem 32 % (13/41) of the SCCIT-positive animals 219 
had visible lesions (VL; 3 Multiple, 10 Diffuse). Of the animals in the VL group, 85 % 220 
(11/13) had detectable mycobacteraemia based on the phage-RPA results (Table 4; Fig. 221 
2). In samples from NVL animals only 57% (16/28) had detectable levels of MTC 222 
mycobacteria in their blood (Fig. 2). No post mortem results were available for the 223 
negative control group, as blood samples were taken from healthy animals.  224 
    Since the phage assay detects individual mycobacterial cells, the number of plaques 225 
detected is indicative of the microbial load in the blood sample. In the SCCIT-positive VL 226 
group, the average number of cells detected in phage-RPA positive samples was 30.4 227 
(range = 8-63 pfu per 2 ml blood; Fig. 3). For the SCCIT-positive NVL group, the 228 
average number of cells detected in RPA-positive samples was 16.3 (range = 2-43 pfu 229 
per 2 ml blood; Fig. 3) and this number is significantly lower than the number of 230 
mycobacterial cells detected in the VL samples (p < 0.05) suggesting that the VL 231 
animals had a higher microbial load in the blood. Within the NVL group, the average 232 
plaque number for MTC-negative samples (phage-negative or phage positive, RPA-233 
negative) was 2.3 (range = 0-16; Fig. 3) and this number was also significantly lower (p 234 
< 0.05) than the plaque number for the NVL-MTC positive samples (Fig.3).  235 
 236 
Discussion 237 




    The bacteriophage-based detection method used here was originally developed as a 238 
commercial assay for the detection of human M. tuberculosis infections,20 however more 239 
recently it has been shown to be a useful tool for the investigation of animal 240 
mycobacterial infections, such as Johne’s disease.13, 16 Combining phage-based detection 241 
with PCR-based identification methods allows both live/dead differentiation (the phage 242 
can only replicate in a viable cell) and also increases the sensitivity of PCR-based 243 
detection methods because the plaques formed allow efficient targeting of the genomic 244 
DNA released from individual cells which is preserved in the agar. The IS6110 genetic 245 
element, although not specific for M. bovis, is extremely useful as a target for any DNA-246 
based detection method, as it is present in multiple copies in the genome, allowing more 247 
sensitive detection of single cells. Although components of the PBMC fraction does not 248 
affect the phage-based assay, RPA was chosen as an alternative DNA amplification 249 
method since it is reported to be less susceptible to inhibition by blood,21 and in this 250 
study the RPA detection of low concentrations of IS6110 was found to be more 251 
reproducible than PCR-based amplification of the same signature sequences.  252 
    As we found that MAP cells were primarily located in the PBMCs of MAP-infected 253 
cattle,16 we hypothesised that this may also be true for cattle suffering from M. bovis 254 
infection. Hence for this study the SCCIT-positive cattle were chosen simply to determine 255 
whether mycobacteraemia could be detected in the blood of these animals using the 256 
phage-RPA method. The fact that we detected viable MTC cells in the blood of 26 of the 257 
41 animals tested is extremely interesting and demonstrates that SCCIT reactor animals 258 
(i.e those identified as infected by M. bovis) commonly contain detectable levels of viable 259 
mycobacteria within PBMCs. Although there is a lack of other reports describing the 260 
detection of M. bovis in the blood of cattle (apart from one study in 19776), there are 261 
many publications that have demonstrated the detection of mycobacteria in blood for 262 
humans suffering from human tuberculosis by both culture and PCR.22, 23   263 
    In this study we have not used a signature sequence that is specific for M. bovis, 264 
rather we targeted the IS6110 element which is specific for the MTC group of which M. 265 
bovis is a member. Targeting this well-characterised genetic element allows rapid and 266 




sensitive detection which can be routinely used for a variety of applications, making the 267 
IS6110 genetic element a useful target despite the lack of specificity. Nonetheless as all 268 
the animals tested were SCCIT test positive, and M. bovis was cultured from some 269 
samples from this outbreak sent to the UK veterinary diagnostic laboratories (D Brewer, 270 
APHA pers. comm.), it is a reasonable interpretation of the results gained in this study 271 
that the cells detected in these samples were M. bovis. While this is true in the UK, other 272 
members of the MTC that may be detected using this method in countries where M. 273 
bovis is not prevalent.  Interestingly none of the samples from control animals gave a 274 
positive result with the IS6110 RPA assay, but it must also be noted these samples were 275 
obtained from live animals rather than at slaughter which may have influenced our 276 
results gained. Samples from six of these animals produce plaques and this may be due 277 
to the presence of a different type of mycobacterial cell, such as MAP, which is also 278 
widespread within UK cattle populations.16  In this study we did not test the samples for 279 
the presence of other mycobacterial signature sequences, but this result emphasises the 280 
fact that when using the phage-based detection method amplification of signature 281 
sequences to confirm the identity of the cell detected is essential for accurate 282 
interpretation of plaque results.  In future studies it will be interesting to include more 283 
specific M. bovis signature sequences as well as developing multiplex DNA amplification 284 
assays such as we have previously described14 to allow simultaneous detection of 285 
different mycobacterial species.  286 
    Of the 41 SCCIT-positive samples tested, only 13 had visible lesions, suggesting these 287 
animals had an advanced stage of infection and MTC cells were not detected in blood 288 
samples from only two of these. This may have been because there was low bacterial 289 
load in these blood samples which was not detectable by the phage assay. However the 290 
overall pattern of results is consistent with the idea that animals with visible lesions have 291 
a more disseminated infection and therefore perhaps it is not surprising to find that M. 292 
bovis cells are actively replicating inside the PBMCs (phage D29 can only productively 293 
infect actively growing cells10). It is also known that the sensitivity of identifying lesions 294 
at post-mortem is low,24 which may explain why 57% of the NVLs also had detectable 295 




levels of viable mycobacteria in their blood. Despite this, there was a significantly lower 296 
number of plaques detected in the MTC-positive NVL samples than was detected in MTC-297 
positive VL animals indicating a lower microbial load in this group of animals. This may 298 
reflect the ability of the phage assay to detect early stages of infection in some animals, 299 
but further studies on animals in the early stages of infection are required to support this 300 
conclusion. 301 
    The level of mycobacteraemia in animals suffering from M. bovis infection is 302 
underreported due to the difficulties associated with culturing M. bovis from clinical 303 
samples, and therefore this aspect of the disease is not well understood. In human 304 
tuberculosis and in other mycobacterial diseases, mycobacteraemia is considered as one 305 
of the potentially most useful approaches to definitively diagnose tuberculosis.23 306 
However culturing these organisms is very slow, expensive and insensitive, which limits 307 
the use of culture as a Gold Standard when investigating and detecting infectious 308 
diseases.25 Although, several research groups have detected mycobacteraemia using 309 
extraction of DNA and direct PCR, it is not certain whether the DNA detected came from 310 
a viable cell or whether PCR inhibitors in blood limit the detection event.26  The fact that 311 
the phage-RPA method could rapidly and sensitively detect and enumerate viable 312 
mycobacterial cells in clinical blood samples, providing results within 48 h, means that it 313 
could be used to increase our understanding of M. bovis infections. Although parallel 314 
testing with culture is needed, the phage assay may also aid the confirmation of BTB 315 
infection in NVL cattle without the need for extended culture of samples. The blood from 316 
the SCCIT test positive reactor animals was obtained from animals directly after 317 
slaughter which may have impacted our finding compared to obtained samples from live 318 
animals. To this end it would be interesting to know whether intermediate or non-SCCIT 319 
reactor animals from an infected herd harbour mycobacteria in their blood in live 320 
animals, and whether this relates to the probability of their progression to SCCIT-321 
positive status. Hence the phage-RPA provides a useful tool for monitoring levels of 322 
mycobacteraemia in relation to the animals’ immune response to disease, especially 323 




during vaccine trials and will enable researchers to ask clinically important questions to 324 
further the understanding of this extremely difficult to control disease.           325 
Conclusion 326 
    Here we show that the phage-RPA method can be applied to provide rapid, sensitive 327 
and specific detection of MTC cells in clinical blood samples.  The finding that a number 328 
of SCCIT-positive animals with detectable levels of viable MTC cells present in these 329 
initial trial results were both encouraging and surprising, in particular the relationship 330 
seen between mycobacterial load in the blood and the animals’ lesion status.  More work 331 
is now required to develop species-specific RPA assays and to establish what sample 332 
volume is required to ensure sensitive detection of low levels of bacteria.  In addition, 333 
studies specifically designed to investigate exactly how bacteraemia relates to 334 
disseminated infection are required.   335 
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Table 1. Detection of M. bovis BCG in PBMC’s using the phage assay  426 
Approx. No. of BCG cells  
used to inoculate sheep’s blood1 
Avg. Number of Plaques 
detected 
(±SD) 
105 Complete lysis 
104 Confluent lysis 
103 TNTC2 
102 65 (±13) 
101 17 (±4.5) 
1 0 
0 0 
105 – no incubation 0 
 427 
1 ml of M. bovis BCG cells was added to 9 ml of commercial sheep’s blood and incubated 428 
for 4 h at 37 °C.  PBMCs were then isolated and any internalised mycobacteria detected 429 
using the phage assay.  For the “105 - no incubation” sample cells were added to the 430 
blood and then then the buffy coat fraction immediately isolated with no time allowed for 431 
internalisation.  Results are reported as the average ±SD of 3 independent samples. 432 
 433 
1The number of cells in the inoculum was determined using the phage assay and 434 
represents the number of detectable cells added to the sample 435 
2TNTC – Too Numerous to Count  436 




Table 2. Performance of different amplification methods to Detect MTC 437 
signature sequences  438 
 
Detection of MTC Signature Sequences in DNA extracted 
from plaques1 
No. of M. bovis Plaques2 IS6110 (PCR)3 IS6110 (RPA)4 IS1081 (RPA)4 
5 + + + 
4 + + + 
3 + + + 
2 +/- + +/- 
1 +/- + - 
 439 
M. bovis cells were mixed with purified sheep PMBCs and then the phage assay carried 440 
out to generate M. bovis plaques. M. smegmatis plaques were recovered from plates of 441 
the routine positive control samples.   442 
1 Result reported on the basis of the results of three independent tests  443 
2 DNA was extracted from 5 plaques for each test sample, but the number of M. bovis 444 
plaques used varied between 1 and 5; plaques formed following the detection of M. 445 
smegmatis cells were added to samples to keep the volume of agar being tested 446 
consistent (approx. 50 µl).   447 
+ : Denotes a positive amplification of target sequence for all samples (n=3); - :  448 
Denotes no amplification of the target sequence (n=3); +/- : Denotes both positive and 449 
negative amplification of the target sequence when three replicates were performed.  450 




Table 3. Detection of viable MTC bacteria in PBMCs isolated from a SCCIT-451 
negative herd 452 
Assigned Number No. of Plaques IS6110 RPA 
1 0 NA 
2 0 NA 
3 0 NA 
4 0 NA 
5 0 NA 
6 0 NA 
7 0 NA 
8 0 NA 
9 1 -ve 
10 0 NA 
11 0 NA 
12 0 NA 
13 0 NA 
14 0 NA 
15 0 NA 
16 0 NA 
17 0 NA 
18 0 NA 
19 0 NA 
20 0 NA 
21 0 NA 
22 0 NA 
23 0 NA 
24 0 NA 
25 0 NA 
26 0 NA 
27 0 NA 
28 0 NA 
29 11 -ve 
30 2 -ve 
31 3 -ve 
32 1 -ve 
33 0 NA 
34 0 NA 
35 0 NA 
36 0 NA 
37 1 -ve 
38 0 NA 
39 0 NA 
40 0 NA 
41 0 NA 
42 0 NA 
43 0 NA 
44 0 NA 
45 0 NA 
  453 
NA – Not Applicable as no plaques were formed.   454 




 Table 4. Detection of viable MTC bacteria in PBMCs isolated from SCCIT-455 
positive cattle 456 
Assigned Number No. of Plaques IS6110 RPA Post-Mortem Resultsa 
1 63 +ve Diffuse VL 
2 27 +ve NVL 
3 43 +ve Diffuse VL 
4 22 +ve Diffuse VL 
5 60 +ve Diffuse VL 
6 36 +ve Diffuse VL 
7 11 +ve Diffuse VL 
8 14 +ve Diffuse VL 
9 35 +ve Multiple VL 
10 15 +ve NVL 
11 14 +ve NVL 
12 25 +ve NVL 
13 43 +ve NVL 
14 26 +ve Diffuse VL 
15 3 +ve NVL 
16 4 +ve NVL 
17 5 +ve NVL 
18 20 +ve NVL 
19 7 +ve NVL 
20 0 NA NVL 
21 2 +ve NVL 
22 0 NA NVL 
23 16 +ve Multiple VL 
24 0 NA Diffuse VL 
25 8 +ve Diffuse VL 
26 0 NA NVL 
27 8 +ve NVL 
28 7 -ve NVL 
29 0 NA NVL 
30 24 +ve NVL 
31 16 -ve NVL 
32 0 NA NVL 
33 0 NA NVL 
34 0 NA Multiple VL 
35 0 NA NVL 
36 8 +ve NVL 
37 32 +ve NVL 
38 23 +ve NVL 
39 3 -ve NVL 
40 1 -ve NVL 
41 0 NA NVL 
a VL, visible lesion; NVL, non-visible lesions. 457 
NA – Not Applicable as no plaques were formed.  458 





Fig. 1. Schematic of the bacteriophage amplification assay 460 
To perform the phage assay, the mycobacteria first need to be isolated from the sample.  461 
In all these experiments PBMCs were purified and suspended in supplemented 7H9 462 
medium that lyses the PBMCs and promotes efficient phage infection: Step 1: Isolated 463 
mycobacteria are incubated with phage D29 for 1 h to allow virus infection of 464 
mycobacterial cells present in the sample. Step 2: Extracellular phage that have not 465 
infected bacterial cells are inactivated by virucide. Step 3: Virucide is neutralized and fast-466 
growing M. smegmatis are added to the sample which will form the bacterial lawn. Step 4: 467 
Samples are plated in soft agar and incubated overnight permitting lawn formation by M. 468 
smegmatis. Phage released from the infected mycobacterial cells present in the original 469 
sample are released and infect the M. smegmatis cells resulting in the formation of 470 
plaques. Step 5: Plates are inspected for plaques which indicate detection of a 471 
mycobacterial cell in the original sample. If plaques are present, DNA is extracted from the 472 
agar and presence of MTC bacteria is determined by RPA/PCR. 473 







Fig. 2. Frequency of detection of MTC-bacteraemia in VL and NVL groups 477 
Distribution of MTC bacteraemia-positive (Dark Grey) and MTC bacteraemia-negative 478 
(Light Grey) samples for animals classified as having visible lesions (VL) or non-visible 479 









































Fig. 3.  Average plaque number detected for SCCIT positive and negative VL and 482 
NVL samples 483 
Average number of plaques (±SD) formed per 2 ml blood sample for SCCIT positive 484 
animals that were classified as having visible lesions (VL; n=13) or non-visible lesions 485 
(NVL; n=28) at post mortem or SCCIT negative animals (n=45).  Samples are further 486 
divided into those that gave a positive IS6110-RPA result (dark grey) and those that 487 
either formed no plaques or gave a negative IS6110 RPA result (Light Grey). One-way 488 
ANOVA and Post-hoc Dunnetts-test was used to determine differences between these 489 
data sets. 490 
